From the first booster dose to returning home with your microdose supply — here is exactly what happens, when, and why.
Every experience is unique, but these themes emerge consistently across our 900+ patient histories.
About 60–70% of patients report vivid visual experiences during the first 4–8 hours. These can range from geometric patterns to detailed autobiographical memories playing back like a film. The visionary phase is not universal and its absence does not indicate reduced therapeutic efficacy.
The most frequently reported phenomenon: a panoramic review of significant life events, often from childhood through present. Patients describe watching their life 'from the outside' with profound clarity about cause-and-effect patterns in their choices and relationships.
Crying, laughing, or experiencing waves of emotion during the experience is normal and therapeutically valuable. Ibogaine surfaces suppressed emotional material for processing. Our staff is trained to provide compassionate, non-intrusive support during these releases.
Ataxia (loss of coordination), buzzing or vibrating sensations, temperature changes, and nausea are common physical effects. You will be lying comfortably in bed throughout. Anti-nausea medication is available. These sensations pass as the medicine processes.
In the days and weeks following treatment, most patients report heightened clarity, emotional openness, reduced cravings, improved mood, and a sense of possibility. This 'afterglow' reflects ibogaine-induced neuroplasticity — the brain is literally more adaptable during this window.
Sleep disruption for 2–5 nights post-treatment is common and resolves without intervention. Ibogaine stimulates the central nervous system. Melatonin, magnesium, and sleep hygiene guidance are provided. This is a known, managed effect — not a complication.
About 60–70% of patients experience visual or dreamlike states during the first 4–8 hours. These are not 'hallucinations' in the recreational sense — they are introspective, often autobiographical visions. Some patients have a deeply visual experience; others report only physical and emotional processing with no visuals at all. The therapeutic effect does not depend on visions.
The experience is physically uncomfortable for some (nausea, ataxia, temperature fluctuations) but not typically painful. Anti-nausea medication is available throughout. Emotionally, ibogaine can surface difficult memories and emotions — this is the therapeutic mechanism. Our psychologist and clinical team are present to support you through every phase.
The acute experience lasts 18–24 hours from administration. The visionary phase is typically 4–8 hours, followed by a longer processing and rest phase. Most patients are mobile by day 2 post-treatment and feel increasingly clear from day 3 onward. The metabolite noribogaine continues working for weeks, which is why our microdose protocol extends benefits for 90 days.
Yes — ibogaine is not anesthesia. You remain conscious throughout, though your state of awareness shifts significantly. During the peak phase, you are deeply inward-focused with eyes closed. You can communicate with staff via hand squeeze. After 12–16 hours, normal conversation resumes gradually. You are monitored continuously the entire time.
Ibogaine surfaces whatever needs to be processed, which can include difficult emotions. Our clinical team has guided 900+ patients through every possible variation of the experience. A trained nurse or physician is always present. Benzodiazepines are available if acute anxiety requires intervention (rarely needed). The therapeutic frame is designed for safety at every level.
You fast for 6–8 hours before administration (light breakfast, then nothing). During the acute phase (first 12–18 hours), eating is not possible or desired. IV fluids maintain hydration. After hour 18–24, small sips of water and light broth are introduced. Normal eating resumes gradually over days 2–3. We prepare nutrient-dense meals designed for post-treatment recovery.
Start with a free eligibility screening — a confidential review of your medical history, medications, and treatment goals. No commitment. Just clarity about whether ibogaine is right for you.